跳至主要内容
临床试验/IRCT20200325046854N1
IRCT20200325046854N1招募中2 期

Evaluation of the efficacy of apixaban in the treatment of heparin-induced thrombocytopenia (HIT)

Iran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • 1) Age 18 years or older
  • 2) HIT detection based on 4T Score equal to or above 4

排除标准

  • Patients with active bleeding
  • Patient with inherited or acquired coagulation disease or bleeding disorder
  • Patients receiving cytochrome P-450 3A4 inhibitors or inducers
  • Severe renal failure (CrCl <25 ml / min)
  • Severe liver disease (including Child-Pugh B and C)
  • The patient needs surgery
  • History of uncorrected cerebral aneurysm, intracranial tumor or vascular accident
  • Non-participation in research projects during the 30 days prior to the study
  • Pregnant and lactating women
  • Previous treatment with a non-heparin anticoagulant
  • Covid-19 infection

研究者

相似试验